TransMedics to Present at Upcoming March Investor Conferences

Rhea-AI Summary

TransMedics Group (Nasdaq: TMDX), a medical technology company focused on transforming organ transplant therapy, has announced its participation in two major investor conferences in March 2025. The company will present at:

1. The TD Cowen 45th Annual Health Care Conference in Boston on March 3, 2025, at 11:50 a.m. EST

2. The Oppenheimer 35th Annual Healthcare MedTech & Services Conference virtually on March 17, 2025, at 9:20 a.m. EST

Interested parties can access live and archived webcasts of both presentations through the 'Investors' section of TransMedics' website. The company's standard investor presentation will also be available through the same platform.

ANDOVER, Mass., Feb. 18, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the TD Cowen 45^th Annual Health Care Conference in Boston on Monday, March 3, 2025, at 11:50 a.m. EST and virtually at the Oppenheimer 35^th Annual Healthcare MedTech & Services Conference on Monday, March 17, 2025, at 9:20 a.m. EST.

Event: TD Cowen 45^th Annual Health Care Conference
Date: Monday, March 3, 2025
Time: 11:50 a.m. EST

Event: Oppenheimer 35^th Annual Healthcare MedTech & Services Conference
Date: Monday, March 17, 2025
Time: 9:20 a.m. EST

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-march-investor-conferences-302379372.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics (TMDX) presenting at the TD Cowen Healthcare Conference in March 2025?

TransMedics will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 11:50 a.m. EST in Boston.

What time is TransMedics' (TMDX) presentation at the Oppenheimer Healthcare Conference in March 2025?

TransMedics will present virtually at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference on Monday, March 17, 2025, at 9:20 a.m. EST.

How can investors access TransMedics' (TMDX) March 2025 conference presentations?

Investors can access live and archived webcasts of the presentations through the 'Investors' section of TransMedics' website at https://investors.transmedics.com/.

Which investor conferences is TransMedics (TMDX) attending in March 2025?

TransMedics is attending the TD Cowen 45th Annual Health Care Conference in Boston and the Oppenheimer 35th Annual Healthcare MedTech & Services Conference virtually in March 2025.